FDA aims to speed up arrival of complex generic drugs
WASHINGTON (Reuters) – The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV’s emergency EpiPen in an effort to address the rising cost of pharmaceuticals. The measures, announced in a blog post by Commissioner Scott Gottlieb, stray into […]
Read More